| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.
|
Prostate
|
1999
|
4.12
|
|
2
|
The impact of family history on early detection of prostate cancer.
|
Nat Med
|
1995
|
2.14
|
|
3
|
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
1997
|
2.10
|
|
4
|
Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
|
J Clin Endocrinol Metab
|
1997
|
1.96
|
|
5
|
Serum prostate specific antigen as pre-screening test for prostate cancer.
|
J Urol
|
1992
|
1.84
|
|
6
|
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.
|
J Clin Endocrinol Metab
|
1994
|
1.66
|
|
7
|
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.
|
Clin Invest Med
|
1982
|
1.65
|
|
8
|
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen.
|
Urology
|
1996
|
1.56
|
|
9
|
Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.
|
Am J Med
|
1992
|
1.50
|
|
10
|
Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma.
|
Eur J Cancer Clin Oncol
|
1988
|
1.38
|
|
11
|
DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.
|
Steroids
|
1998
|
1.35
|
|
12
|
Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men.
|
J Steroid Biochem
|
1989
|
1.18
|
|
13
|
Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
|
J Clin Endocrinol Metab
|
1997
|
1.10
|
|
14
|
Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study.
|
Am J Surg Pathol
|
1996
|
1.08
|
|
15
|
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
|
J Clin Endocrinol Metab
|
1997
|
1.02
|
|
16
|
Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy.
|
Urology
|
1999
|
1.00
|
|
17
|
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
|
Prostate
|
2000
|
0.99
|
|
18
|
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
|
Clin Invest Med
|
1993
|
0.96
|
|
19
|
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
|
J Steroid Biochem Mol Biol
|
1999
|
0.94
|
|
20
|
Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy.
|
J Urol
|
1993
|
0.92
|
|
21
|
Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
|
J Endocrinol
|
1996
|
0.89
|
|
22
|
Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, Des-Gly-NH210] LHRH ethylamide.
|
Endocrinology
|
1978
|
0.89
|
|
23
|
Beta-endorphin: stimulation of growth hormone release in vivo.
|
Proc Natl Acad Sci U S A
|
1977
|
0.89
|
|
24
|
Cellular localization of the Mn2+-dependent adenylyl cyclase in the human testis.
|
Arch Androl
|
1982
|
0.87
|
|
25
|
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia.
|
Climacteric
|
2011
|
0.86
|
|
26
|
Neoadjuvant hormonal therapy: the Canadian experience.
|
Urology
|
1997
|
0.85
|
|
27
|
Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats.
|
Endocrinology
|
1979
|
0.85
|
|
28
|
Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat.
|
Mol Cell Endocrinol
|
1981
|
0.85
|
|
29
|
Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
|
Clin Invest Med
|
1993
|
0.84
|
|
30
|
Potent prolactin and growth hormone releasing activity of more analogues of Met-enkephalin.
|
Nature
|
1977
|
0.84
|
|
31
|
Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult men.
|
J Steroid Biochem
|
1989
|
0.84
|
|
32
|
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
|
J Steroid Biochem
|
1987
|
0.82
|
|
33
|
Steroid glucuronides: human circulatory levels and formation by LNCaP cells.
|
J Steroid Biochem Mol Biol
|
1991
|
0.82
|
|
34
|
Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women.
|
J Steroid Biochem Mol Biol
|
2007
|
0.81
|
|
35
|
[Validation of a French adaptation of the international prostatic symptom score].
|
Prog Urol
|
1996
|
0.80
|
|
36
|
Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report.
|
Am J Med
|
1992
|
0.80
|
|
37
|
Plasma levels of hydroxy-flutamide in patients with prostatic cancer receiving the combined hormonal therapy: an LHRH agonist and flutamide.
|
Prostate
|
1988
|
0.80
|
|
38
|
Ovarian progestins, androgens and estrogen throughout the 4-day estrous cycle in the rat.
|
Biol Reprod
|
1981
|
0.80
|
|
39
|
Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.
|
J Clin Endocrinol Metab
|
1988
|
0.80
|
|
40
|
Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues in vivo and in vitro.
|
Life Sci
|
1977
|
0.80
|
|
41
|
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomy.
|
Cancer Surv
|
1995
|
0.79
|
|
42
|
Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide.
|
Fertil Steril
|
1990
|
0.79
|
|
43
|
Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinoma.
|
Br J Urol
|
1993
|
0.78
|
|
44
|
Characterization of protein carboxyl methylase activities in rat testis: presence of testis specific charge isomers.
|
Arch Androl
|
1981
|
0.78
|
|
45
|
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapy.
|
Br J Urol
|
1989
|
0.78
|
|
46
|
Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.
|
Int J Fertil
|
1980
|
0.78
|
|
47
|
Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate.
|
J Steroid Biochem
|
1987
|
0.77
|
|
48
|
Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function.
|
Adv Exp Med Biol
|
1979
|
0.77
|
|
49
|
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist.
|
Horm Res
|
1983
|
0.77
|
|
50
|
Inhibition of ovarian luteinizing hormone (LH) and follicle-stimulating hormone receptor levels with an LH-releasing hormone agonist during the estrous cycle in the rat.
|
Fertil Steril
|
1978
|
0.77
|
|
51
|
Stratification of stage D2 prostate cancer patients by a disease aggressiveness score and its use in evaluating disease response and outcome to combination hormonal treatment (GnRH-A plus flutamide).
|
Anticancer Res
|
1994
|
0.77
|
|
52
|
Inhibitory effect of a luteinizing hormone (LH)-releasing hormone agonist on rat ovarian LH and follicle-stimulating hormone receptor levels during pregnancy.
|
Fertil Steril
|
1978
|
0.77
|
|
53
|
Impairment of pituitary and gonadal functions in alloxan-induced diabetic male rats.
|
Mol Cell Endocrinol
|
1980
|
0.77
|
|
54
|
Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.
|
Prostate
|
1996
|
0.77
|
|
55
|
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer.
|
J Steroid Biochem
|
1989
|
0.76
|
|
56
|
Rat sperm enzymes during epididymal transit.
|
J Reprod Fertil
|
1982
|
0.76
|
|
57
|
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma.
|
Eur J Cancer Clin Oncol
|
1988
|
0.76
|
|
58
|
beta-Endorphin and met-enkephalins: their distribution, modulation by estrogens and haloperidol, and role in neuroendocrine control.
|
Fed Proc
|
1980
|
0.76
|
|
59
|
Relative importance of the adenohypophyseal and gonadal sites in inhibitory action of LHRH agonists.
|
Biol Reprod
|
1981
|
0.76
|
|
60
|
Stimulation of prolactin release in the rat by intraventricular injection of beta-endorphin and methionine-enkephalin.
|
Biochem Biophys Res Commun
|
1977
|
0.76
|
|
61
|
Effect of an LHRH analog on growth and hormone receptor levels in DMBA-induced mammary tumors in the rat.
|
J Recept Res
|
1981
|
0.76
|
|
62
|
Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report.
|
Clin Invest Med
|
1990
|
0.76
|
|
63
|
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice.
|
J Steroid Biochem
|
1988
|
0.76
|
|
64
|
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.
|
Prog Clin Biol Res
|
1989
|
0.75
|
|
65
|
Adenylyl cyclase and protein carboxyl methylase in human spermatozoa.
|
Arch Androl
|
1982
|
0.75
|
|
66
|
Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
|
J Clin Endocrinol Metab
|
1991
|
0.75
|
|
67
|
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
|
J Urol
|
1991
|
0.75
|
|
68
|
Increased testicular 5 alpha-androstane-3 alpha, 17 beta-diol formation induced by treatment with [D-Ser (TBU) 6, des-Gly-NH2(10)] LHRH ethylamide in the rat.
|
Steroids
|
1980
|
0.75
|
|
69
|
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogen.
|
J Steroid Biochem
|
1983
|
0.75
|
|
70
|
[Inhibition of testicular steroidogenesis in the rat following administration of an LHRH agonist].
|
Union Med Can
|
1980
|
0.75
|
|
71
|
Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience.
|
Cancer Metastasis Rev
|
1987
|
0.75
|
|
72
|
[Inhibition of gonadal function by LHRH and their agonists in the male and female rat].
|
Union Med Can
|
1978
|
0.75
|
|
73
|
Contraception with LHRH agonists, a new physiological approach.
|
Reproduccion
|
1982
|
0.75
|
|
74
|
Physiological role of endorphins in neuroendocrinology.
|
Acta Physiol Pol
|
1981
|
0.75
|
|
75
|
Octreotide and bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castration.
|
Eur J Cancer
|
1990
|
0.75
|
|
76
|
Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancer.
|
Recent Results Cancer Res
|
1992
|
0.75
|
|
77
|
Effects of castration, sex steroids, LHRH and glucocorticoids on LHRH binding in the anterior pituitary of male rats.
|
Int J Androl
|
1981
|
0.75
|
|
78
|
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
|
Prog Clin Biol Res
|
1981
|
0.75
|
|
79
|
[Total androgen blockade: an argument in favor].
|
Union Med Can
|
1989
|
0.75
|
|
80
|
Regulation of steroidogenesis and steroid action in Leydig cells.
|
J Steroid Biochem
|
1981
|
0.75
|
|
81
|
Evidence for a role of endorphins in stress- and suckling-induced prolactin release in the rat.
|
Mol Cell Endocrinol
|
1978
|
0.75
|
|
82
|
Protein carboxylmethylase and germ cell adenylyl cyclase at specific stages of the spermatogenic cycle of the rat.
|
Biol Reprod
|
1981
|
0.75
|
|
83
|
Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality.
|
J Clin Endocrinol Metab
|
1995
|
0.75
|
|
84
|
Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience.
|
J Steroid Biochem Mol Biol
|
1990
|
0.75
|
|
85
|
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
|
Clin Invest Med
|
1988
|
0.75
|
|
86
|
Major advantages of "early" administration of endocrine combination therapy in advanced prostate cancer.
|
Clin Invest Med
|
1993
|
0.75
|
|
87
|
[Inhibitory effects of LHRH on LH receptors in the rat testis].
|
C R Acad Sci Hebd Seances Acad Sci D
|
1978
|
0.75
|
|
88
|
Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experience.
|
Prog Clin Biol Res
|
1988
|
0.75
|
|
89
|
Stimulatory effect of luteinizing hormone and human chorionic gonadotropin on testicular prolactin receptor levels.
|
Biol Reprod
|
1980
|
0.75
|
|
90
|
Effect of an LHRH agonist and hCG on testicular steroidogenesis in the adult rat.
|
Biol Reprod
|
1980
|
0.75
|
|
91
|
Desensitization of FSH-responsive adenylyl cyclase in cultured immature Sertoli cells by homologous hormone.
|
Arch Androl
|
1982
|
0.75
|
|
92
|
Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women.
|
Maturitas
|
1991
|
0.75
|
|
93
|
Changes in protein carboxyl-methylase isoenzymes during testicular development in the rat.
|
Arch Androl
|
1982
|
0.75
|